RecruitingNCT06581692

Non-invasive Monitoring of Miscarriage


Sponsor

Chinese University of Hong Kong

Enrollment

150 participants

Start Date

Sep 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

cfDNA is extremely useful to ascertain chromosomal causes of miscarriages at the point of miscarriage diagnosis by a simple blood test. This study aims to determine the level of cell-free DNA (cfDNA) in early pregnancy and compare the results with those of product of conception (POC) testing, in concordance with standard karyotyping.


Eligibility

Min Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying This is a routine procedure, no intervention will be provided. for people with miscarriage in first trimester. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERThis is a routine procedure, no intervention will be provided.

This is a routine procedure, no intervention will be provided.


Locations(1)

Prince of Wales Hospital

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06581692


Related Trials